Evaluation of blood and urine based biomarkers for detection of clinically-significant prostate cancer
Hunter S. Robinson(Vanderbilt University Medical Center), Jeffrey J. Tosoian(Johns Hopkins University), Sangmyung S. Lee(Vanderbilt University Medical Center), Daniel A. Barocas(Vanderbilt University Medical Center)
Cited by 19
Related Papers
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
|The Lancet|2018|779
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2023|592
Diagnosis, Evaluation and Follow-Up of Asymptomatic Microhematuria (AMH) in Adults: AUA Guideline
|The Journal of Urology|2012|487
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
|The Journal of Urology|2022|462
Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening
|The Journal of Urology|2023|368